Namrata Singh, MD, MSc

University of Washington
Bellevue, WA, United States

Clinical researcher conducting health outcomes based research.

Disclosure information not submitted.

Presentation(s):

• 0928: Use of Disease Modifying Anti-rheumatic Drugs and Risk of Multiple Myeloma in US Veterans with Rheumatoid Arthritis

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 13S127: The Great Debate: To Treat or Not? The Role of DMARDS in Subclinical Rheumatoid Arthritis

  Sunday, November 13, 2022
  10:30 AM – 11:30 AM Eastern Time

• 1210: Use of Biologic or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs and the Risk of Lymphoma in Rheumatoid Arthritis

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time

• 597: CH Aging: Interdisciplinary Discussion and Assessment and Management of Pain in Older Adults with Mild Cognitive Impairment and Dementia Viewpoint

  Sunday, November 13, 2022
  6:00 PM – 6:45 PM Eastern Time

• 14M114: Abstracts: RA – Diagnosis, Manifestations, and Outcomes II: Cardiovascular and Other Comorbidities (1646–1650)

  Monday, November 14, 2022
  9:00 AM – 10:00 AM Eastern Time

• 14M135: State-of-the-Art: The Jury on JAKs: JAK Inhibitors’ Future in Rheumatic Diseases

  Monday, November 14, 2022
  12:00 PM – 1:00 PM Eastern Time

• 2218: Frailty Is Associated with Serious Infections in Biologic and Targeted-synthetic DMARD Treated Patients with Rheumatoid Arthritis

  Monday, November 14, 2022
  3:45 PM – 3:55 PM Eastern Time